title: Anecortave may help choroidal neovascularization regression in serpiginous choroiditis.
authors.forename: Mário Junqueira
authors.initials: MJ
authors.lastname: Nóbrega
authors.forename: Evandro Luís
authors.initials: EL
authors.lastname: Rosa
authors.forename: Rubens
authors.initials: R
authors.lastname: Belfort
authors.forename: Michel Eid
authors.initials: ME
authors.lastname: Farah
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D002833:Choroiditis / Q000150:complications*; D005260:Female; D006801:Humans; D011244:Pregnadienediols / Q000627:therapeutic use*; D041623:Tomography, Optical Coherence; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D011244:Pregnadienediols; C418047:anecortave acetate